Simon A Mahler1, Robert F Riley2, Brian C Hiestand2, Gregory B Russell2, James W Hoekstra2, Cedric W Lefebvre2, Bret A Nicks2, David M Cline2, Kim L Askew2, Stephanie B Elliott2, David M Herrington2, Gregory L Burke2, Chadwick D Miller2. 1. From the Department of Emergency Medicine (S.A.M., B.C.H., J.W.H., C.W.L., B.A.N., D.M.C., K.L.A., S.B.E., C.D.M.), Division of Cardiology, Department of Internal Medicine (R.F.R., D.M.H.), Department of Biostatistical Sciences (G.B.R.), and Division of Public Health Sciences (G.L.B.), Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC. smahler@wakehealth.edu. 2. From the Department of Emergency Medicine (S.A.M., B.C.H., J.W.H., C.W.L., B.A.N., D.M.C., K.L.A., S.B.E., C.D.M.), Division of Cardiology, Department of Internal Medicine (R.F.R., D.M.H.), Department of Biostatistical Sciences (G.B.R.), and Division of Public Health Sciences (G.L.B.), Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Abstract
BACKGROUND: The HEART Pathway is a decision aid designed to identify emergency department patients with acute chest pain for early discharge. No randomized trials have compared the HEART Pathway with usual care. METHODS AND RESULTS: Adult emergency department patients with symptoms related to acute coronary syndrome without ST-elevation on ECG (n=282) were randomized to the HEART Pathway or usual care. In the HEART Pathway arm, emergency department providers used the HEART score, a validated decision aid, and troponin measures at 0 and 3 hours to identify patients for early discharge. Usual care was based on American College of Cardiology/American Heart Association guidelines. The primary outcome, objective cardiac testing (stress testing or angiography), and secondary outcomes, index length of stay, early discharge, and major adverse cardiac events (death, myocardial infarction, or coronary revascularization), were assessed at 30 days by phone interview and record review. Participants had a mean age of 53 years, 16% had previous myocardial infarction, and 6% (95% confidence interval, 3.6%-9.5%) had major adverse cardiac events within 30 days of randomization. Compared with usual care, use of the HEART Pathway decreased objective cardiac testing at 30 days by 12.1% (68.8% versus 56.7%; P=0.048) and length of stay by 12 hours (9.9 versus 21.9 hours; P=0.013) and increased early discharges by 21.3% (39.7% versus 18.4%; P<0.001). No patients identified for early discharge had major adverse cardiac events within 30 days. CONCLUSIONS: The HEART Pathway reduces objective cardiac testing during 30 days, shortens length of stay, and increases early discharges. These important efficiency gains occurred without any patients identified for early discharge suffering MACE at 30 days. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique Identifier: NCT01665521.
RCT Entities:
BACKGROUND: The HEART Pathway is a decision aid designed to identify emergency department patients with acute chest pain for early discharge. No randomized trials have compared the HEART Pathway with usual care. METHODS AND RESULTS: Adult emergency department patients with symptoms related to acute coronary syndrome without ST-elevation on ECG (n=282) were randomized to the HEART Pathway or usual care. In the HEART Pathway arm, emergency department providers used the HEART score, a validated decision aid, and troponin measures at 0 and 3 hours to identify patients for early discharge. Usual care was based on American College of Cardiology/American Heart Association guidelines. The primary outcome, objective cardiac testing (stress testing or angiography), and secondary outcomes, index length of stay, early discharge, and major adverse cardiac events (death, myocardial infarction, or coronary revascularization), were assessed at 30 days by phone interview and record review. Participants had a mean age of 53 years, 16% had previous myocardial infarction, and 6% (95% confidence interval, 3.6%-9.5%) had major adverse cardiac events within 30 days of randomization. Compared with usual care, use of the HEART Pathway decreased objective cardiac testing at 30 days by 12.1% (68.8% versus 56.7%; P=0.048) and length of stay by 12 hours (9.9 versus 21.9 hours; P=0.013) and increased early discharges by 21.3% (39.7% versus 18.4%; P<0.001). No patients identified for early discharge had major adverse cardiac events within 30 days. CONCLUSIONS: The HEART Pathway reduces objective cardiac testing during 30 days, shortens length of stay, and increases early discharges. These important efficiency gains occurred without any patients identified for early discharge suffering MACE at 30 days. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique Identifier: NCT01665521.
Authors: C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Robert E O'Connor; Leo Bossaert; Hans-Richard Arntz; Steven C Brooks; Deborah Diercks; Gilson Feitosa-Filho; Jerry P Nolan; Terry L Vanden Hoek; Darren L Walters; Aaron Wong; Michelle Welsford; Karen Woolfrey Journal: Circulation Date: 2010-10-19 Impact factor: 29.690
Authors: Chadwick D Miller; Wenke Hwang; Doug Case; James W Hoekstra; Cedric Lefebvre; Howard Blumstein; Craig A Hamilton; Erin N Harper; W Gregory Hundley Journal: JACC Cardiovasc Imaging Date: 2011-08
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: A Jacob Six; Louise Cullen; Barbra E Backus; Jaimi Greenslade; William Parsonage; Sally Aldous; Pieter A Doevendans; Martin Than Journal: Crit Pathw Cardiol Date: 2013-09
Authors: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Alice K Jacobs Journal: Circulation Date: 2011-03-28 Impact factor: 29.690
Authors: Harold I Litt; Constantine Gatsonis; Brad Snyder; Harjit Singh; Chadwick D Miller; Daniel W Entrikin; James M Leaming; Laurence J Gavin; Charissa B Pacella; Judd E Hollander Journal: N Engl J Med Date: 2012-03-26 Impact factor: 91.245
Authors: Udo Hoffmann; John T Nagurney; Fabian Moselewski; Antonio Pena; Maros Ferencik; Claudia U Chae; Ricardo C Cury; Javed Butler; Suhny Abbara; David F Brown; Alex Manini; John H Nichols; Stephan Achenbach; Thomas J Brady Journal: Circulation Date: 2006-10-30 Impact factor: 29.690
Authors: Simon A Mahler; Jason P Stopyra; Fred S Apple; Robert F Riley; Gregory B Russell; Brian C Hiestand; James W Hoekstra; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; David M Herrington; Gregory L Burke; Chadwick D Miller Journal: Clin Biochem Date: 2017-01-10 Impact factor: 3.281
Authors: Joshua James Oliver; Matthew Jay Streitz; Jessica Marie Hyams; Richard Michael Wood; Yevgeniy Mikhaylovich Maksimenko; Brit Long; Robert Michael Barnwell; Michael David April Journal: Intern Emerg Med Date: 2018-03-06 Impact factor: 3.397
Authors: Nicholas D Hartman; Erin N Harper; Lauren M Leppert; Brittany M Browning; Kim Askew; David E Manthey; Simon A Mahler Journal: J Healthc Qual Date: 2018 Jan/Feb Impact factor: 1.095
Authors: Lane M Smith; Nicklaus P Ashburn; Anna C Snavely; Jason P Stopyra; Kristin M Lenoir; Brian J Wells; Brian C Hiestand; David M Herrington; Chadwick D Miller; Simon A Mahler Journal: Emerg Med J Date: 2020-08-04 Impact factor: 2.740